53 results on '"Lagrange, Jean-Léon"'
Search Results
2. Predicting Frailty and Geriatric Interventions in Older Cancer Patients: Performance of Two Screening Tools for Seven Frailty Definitions—ELCAPA Cohort
3. OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer
4. Localisation uro-génitale
5. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
6. Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy
7. Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)
8. Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial
9. Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group
10. Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial
11. Alterations in comprehensive geriatric assessment decrease survival of elderly patients with cancer
12. Radiothérapie pratique des métastases osseuses : indications et techniques
13. Importance de la réunion de concertation pluridisciplinaire (RCP) dans la prise en charge des localisations osseuses du myélome et des tumeurs solides
14. Performance of Four Frailty Classifications in Older Patients With Cancer: Prospective Elderly Cancer Patients Cohort Study
15. What Do Older Adults Know About Their Cancer Diagnosis and Treatment? The ELCAPA‐08 Cohort Study
16. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial
17. Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity
18. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU)
19. Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial
20. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial
21. Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer
22. Random Forests to Predict Rectal Toxicity Following Prostate Cancer Radiation Therapy
23. Métastases osseuses : les nouvelles techniques d’irradiation et traitements combinés ablatifs décalent-ils les standards ?
24. Prise en charge par radiothérapie des métastases osseuses et de leurs complications : les standards
25. Nomograms to predict late urinary toxicity after prostate cancer radiotherapy
26. Cost of prostate image-guided radiation therapy: Results of a randomized trial
27. International Patterns of Practice in the Management of Radiation Therapy-induced Nausea and Vomiting
28. Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy
29. A phase III trial of docetaxel–estramustine in high-risk localised prostate cancer: A planned analysis of response, toxicity and quality of life in the GETUG 12 trial
30. 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial
31. Quality of Life Assessment After Concurrent Chemoradiation for Invasive Bladder Cancer: Results of a Multicenter Prospective Study (GETUG 97-015)
32. European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey
33. Radiothérapie pratique des métastases osseuses symptomatiques
34. Common Strategy for Adult and Pediatric Medulloblastoma: A Multicenter Series of 253 Adults
35. Long-term results of breast cancer irradiation treatment with low-dose-rate external irradiation
36. In Vivo Fusion of Circulating Fluorescent Cells with Dystrophin-Deficient Myofibers Results in Extensive Sarcoplasmic Fluorescence Expression but Limited Dystrophin Sarcolemmal Expression
37. Anal canal carcinoma: Early-stage tumors ≤10 mm (T1 or Tis): Therapeutic options and original pattern of local failure after radiotherapy
38. Malignant Breast Tumors After Radiotherapy for a First Cancer During Childhood
39. Oxaliplatin–5-Fluorouracil and Ionizing Radiation
40. Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer—preliminary results
41. Sarcoma after Radiation Therapy: Retrospective Multiinstitutional Study of 80 Histologically Confirmed Cases
42. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French Comprehensive Cancer Centers
43. Concomitant B.I.D. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study11Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) was the promoter of this study.22Presented at the 39th annual ASTRO meeting, Orlando, October 19–23, 1997.
44. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood
45. Tumoral platinum concentrations in patients treated with repeated low‐dose cisplatin as a radiosensitizer
46. Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer
47. Protection of testes during radiation treatment by irregular and focused fields of 25 MV X-rays: in vivo evaluation of the absorbed dose
48. Primary bronchogenic squamous cell carcinoma in children: Report of a case and review of the literature
49. Endogenous phosphorylation of soluble enzymes in human red cells Cyclic 3′,5′-AMP-dependent phosphorylation of phosphofructokinae without detectable regulatory effect
50. Development and use of a computer system in a radiotherapy department: SISGRAD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.